Articles about Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
Otsuka Sues Teva to Block Copies of Jynarque Kidney Disease Drug
New details in Big Pharma price-fixing lawsuit suggest lawyers wrote 'polite f-u letters' | BenefitsPRO
Teva scrambles to match 30% Copaxone discounts from Mylan's knockoff: analyst | Fierce Pharma
Teva Pharmaceutical Industries Ltd.
483 Reports: TEVA Pharmaceuticals USA Inc. - GMP Trends
Attorney Carter G. Phillips, representing generic drug maker Mylan Pharmaceuticals, departs the Supreme Court in Washington, Wednesday, Oct. 15, 2014, after arguments in Teva Pharmaceuticals U.S.A., Inc. v. Sandoz, Inc. Justices seem
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., 135 S.Ct. 831 (2015): Case Brief Summary - Quimbee
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva considering $2B sale of active pharma ngredients unit | Seeking Alpha
ALBUTEROL SULF 90MCG INH 8.5GM - TEVA PHARMACEUTICALS USA
Teva CEO sees no value now in separating brands, generics businesses | Seeking Alpha
Teva pharmaceuticals usa, inc. - Email Address & Phone Number - Lusha
R.I. will receive more than $100m in latest opioid settlement - The Boston Globe
Patent Docs: Helsinn Healthcare S. A. v. Teva Pharmaceuticals USA, Inc. (2019)
Teva recalls 2 lots of hypertension drug on dissolution issues
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
Digihaler® by Teva Pharmaceuticals USA, Inc.
Patent Docs: Eli Lilly & Co. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2009)
United States Court of Appeals for the Federal Circuit
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva to pay New York $500M for role in opioid crisis - POLITICO
